{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:48:34Z","timestamp":1784753314014,"version":"3.55.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170584"],"award-info":[{"award-number":["82170584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870406"],"award-info":[{"award-number":["81870406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is a global commonly occurring liver disease. However, its exact pathogenesis is not fully understood. The purpose of this study was to quantitatively evaluate the progression of steatosis and fibrosis by examining their distribution, morphology, and co-localization in NAFLD animal models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Six mouse NAFLD groups were established: (1) western diet (WD) group; (2) WD with fructose in drinking water (WDF) group; (3) WDF\u2009+\u2009carbon tetrachloride (CCl4) group, WDF plus intraperitoneal injection of CCl4; (4) high-fat diet (HFD) group, (5) HFD with fructose (HFDF) group; and (6) HFDF\u2009+\u2009CCl4 group, HFDF plus intraperitoneal injection of CCl4. Liver tissue specimens from NAFLD model mice were collected at different time points. All the tissues were serially sectioned for histological staining and second-harmonic generation (SHG)\/two-photon excitation fluorescence imaging (TPEF) imaging. The progression of steatosis and fibrosis was analyzed using SHG\/TPEF quantitative parameters with respect to the non-alcoholic steatohepatitis Clinical Research Network scoring system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>qSteatosis showed a good correlation with steatosis grade (<jats:italic>R<\/jats:italic>: 0.823\u20130.953, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05) and demonstrated high performance (area under the curve [AUC]: 0.617-1) in six mouse models. Based on their high correlation with histological scoring, qFibrosis containing four shared parameters (#LongStrPS, #ThinStrPS, #ThinStrPSAgg, and #LongStrPSDis) were selected to create a linear model that could accurately identify differences among fibrosis stages (AUC: 0.725-1). qFibrosis co-localized with macrosteatosis generally correlated better with histological scoring and had a higher AUC in six animal models (AUC: 0.846-1).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Quantitative assessment using SHG\/TPEF technology can be used to monitor different types of steatosis and fibrosis progression in NAFLD models. The collagen co-localized with macrosteatosis could better differentiate fibrosis progression and might aid in developing a more reliable and translatable fibrosis evaluation tool for animal models of NAFLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1172058","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T13:25:14Z","timestamp":1685712314000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Collagen co-localized with macrovesicular steatosis better differentiates fibrosis progression in non-alcoholic fatty liver disease mouse models"],"prefix":"10.3389","volume":"10","author":[{"given":"Xiao-Xiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ying","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from global burden of disease 2009\u20132019","volume":"75","author":"Golabi","year":"2021","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jhep.2018.07.020","article-title":"A changing landscape of liver transplantation: king HCV is dethroned, ALD and NAFLD take over!","volume":"69","author":"Terrault","year":"2018","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/advances\/nmaa081","article-title":"Animal models of fibrosis in nonalcoholic steatohepatitis: do they reflect human disease?","volume":"11","author":"Ipsen","year":"2020","journal-title":"Adv Nutr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12072-019-10001-4","article-title":"New drugs for NAFLD: lessons from basic models to the clinic","volume":"14","author":"Reimer","year":"2020","journal-title":"Hepatol Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"9646","DOI":"10.3390\/ijms21249646","article-title":"Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: current issues and future perspectives in preclinical and clinical research","volume":"21","author":"Berardo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","article-title":"Animal models for liver disease\u2013a practical approach for translational research","volume":"73","author":"Nevzorova","year":"2020","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1912565","DOI":"10.1001\/jamanetworkopen.2019.12565","article-title":"Association of histologic disease activity with progression of nonalcoholic fatty liver disease","volume":"2","author":"Kleiner","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/labinvest.2016.128","article-title":"Automated evaluation of liver fibrosis in thioacetamide, carbon tetrachloride, and bile duct ligation rodent models using second-harmonic generation\/two-photon excited fluorescence microscopy","volume":"97","author":"Liu","year":"2017","journal-title":"Lab Investig"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/hep.30986","article-title":"qFIBS: an automated technique for quantitative evaluation of fibrosis, inflammation, ballooning, and steatosis in patients with nonalcoholic steatohepatitis","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"064010","DOI":"10.1117\/1.3041159","article-title":"Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies","volume":"13","author":"Sun","year":"2008","journal-title":"J Biomed Opt"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/hep.29090","article-title":"Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e0199166","DOI":"10.1371\/journal.pone.0199166","article-title":"Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"13","author":"Chang","year":"2018","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/1440-1681.12102","article-title":"A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice","volume":"40","author":"Kubota","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet-and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12876-020-01467-w","article-title":"Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)\/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF)","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"ref29","volume-title":"Classification and Regression Trees","author":"Breiman","year":"1984"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"A threshold selection method from gray-level histograms","volume":"9","author":"Otsu","year":"1979","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1258\/ebm.2010.010095","article-title":"Digital analysis of hepatic sections in mice accurately quantitates triglycerides and selected properties of lipid droplets","volume":"235","author":"Ge","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e0197242","DOI":"10.1371\/journal.pone.0197242","article-title":"Automated assessment of steatosis in murine fatty liver","volume":"13","author":"Sethunath","year":"2018","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1177\/0192623320926478","article-title":"Utilization of a deep learning algorithm for microscope-based fatty vacuole quantification in a fatty liver model in mice","volume":"48","author":"Ramot","year":"2020","journal-title":"Toxicol Pathol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41374-019-0315-9","article-title":"Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD\/NASH","volume":"100","author":"De Rudder","year":"2020","journal-title":"Lab Investig"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3748\/wjg.v24.i2.195","article-title":"INT-767 improves histopathological features in a diet-induced Ob\/Ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis","volume":"24","author":"Roth","year":"2018","journal-title":"World J Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2008.01.016","article-title":"Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease","volume":"48","author":"Chalasani","year":"2008","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"8525","DOI":"10.3748\/wjg.v20.i26.8525","article-title":"High fat diet feeding results in gender specific steatohepatitis and inflammasome activation","volume":"20","author":"Ganz","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fphar.2018.00410","article-title":"Progression and regression of hepatic lesions in a mouse model of NASH induced by dietary intervention and its implications in pharmacotherapy","volume":"9","author":"Ding","year":"2018","journal-title":"Front Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jhep.2010.11.021","article-title":"Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease","volume":"55","author":"Tandra","year":"2011","journal-title":"J Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrm1912","article-title":"Lipid droplets: a unified view of a dynamic organelle","volume":"7","author":"Martin","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"11963","DOI":"10.3390\/ijms140611963","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)","volume":"14","author":"Kanuri","year":"2013","journal-title":"Int J Mol Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","article-title":"Preclinical models of non-alcoholic fatty liver disease","volume":"68","author":"Santhekadur","year":"2018","journal-title":"J Hepatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1172058\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T13:25:18Z","timestamp":1685712318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1172058\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":42,"alternative-id":["10.3389\/fmed.2023.1172058"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1172058","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"article-number":"1172058"}}